Skip to content

Author

Khalid A. Zoghebi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Isorhamnetin Reverses Doxorubicin Resistance in MCF-7/Doxo Cells by Suppressing P-glycoprotein-mediated Drug Efflux and Reactivating Apoptosis

Doxorubicin resistance is a major challenge in breast cancer treatment, leading to cancer recurrence and poor therapeutic outcomes. Therefore, new agents that can overcome chemoresistance are urgently needed. Chemotherapy is widely used as a frontline treatment for breast cancer (BC), but chemoresistance to...

Abdulmajeed M. Jali, Ali Hanbashi, F. Kamli et al. · 0 citations
Open access Sep 2026

Design, synthesis, and preliminary anticancer evaluation of diphenylpropan-1-one derivatives: in vitro, in vivo and in silico studies

A series of diphenylpropan-1-one (DPP) derivatives (4a–4i), rationally designed around a chalcone framework and synthesized via a three-step reaction sequence demonstrated encouraging preliminary anticancer potential and may serve as promising lead molecules for future investigations.

A. Najmi, M. S. Alam, W. Ahsan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.